{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:20:29Z","timestamp":1790367629832,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cld.2020.01.007","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T08:34:38Z","timestamp":1582706078000},"page":"277-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-Term Management"],"prefix":"10.1016","volume":"24","author":[{"given":"Russell","family":"Rosenblatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Gaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2020.01.007_bib1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJM195705302562203","article-title":"Blood ammonia levels in hepatic cirrhosis: their control by the oral administration of neomycin","volume":"256","author":"Fisher","year":"1957","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2020.01.007_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial","volume":"72","author":"Conn","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2020.01.007_bib3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2020.01.007_bib4","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.01.007_bib5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.cgh.2016.04.009","article-title":"Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study","volume":"14","author":"Tapper","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2020.01.007_bib6","article-title":"Validation of risk score in predicting early readmissions in decompensated cirrhotic patients: a model based on the administrative database","author":"Mumtaz","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.01.007_bib7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.aohep.2018.08.001","article-title":"A\u00a0validated risk model for prediction of early readmission in patients with hepatic encephalopathy","volume":"18","author":"Kruger","year":"2019","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2020.01.007_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European association for the study of the liver and the American Association for the Study of Liver Diseases","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.01.007_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/CEOR.S30675","article-title":"Update on the management of cirrhosis - focus on cost-effective preventative strategies","volume":"5","author":"Neff","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"issue":"9","key":"10.1016\/j.cld.2020.01.007_bib10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cgh.2012.05.016","article-title":"In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2020.01.007_bib11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2020.01.007_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ajg.2011.314","article-title":"Hospital readmissions among patients with decompensated cirrhosis","volume":"107","author":"Volk","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2020.01.007_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/IJGM.S81878","article-title":"Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy","volume":"8","author":"Saab","year":"2015","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.cld.2020.01.007_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep4.1137","article-title":"Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis","volume":"2","author":"Chirapongsathorn","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cld.2020.01.007_bib15","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s10620-017-4630-y","article-title":"A\u00a0new look at precipitants of overt hepatic encephalopathy in cirrhosis","volume":"62","author":"Pantham","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2020.01.007_bib16","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-2036.2010.04257.x","article-title":"Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.cld.2020.01.007_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40273-018-0641-6","article-title":"Systematic review of the economic burden of overt hepatic encephalopathy and pharmacoeconomic impact of rifaximin","volume":"36","author":"Neff","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.cld.2020.01.007_bib18","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.23866","article-title":"Drug therapy: rifaximin","volume":"52","author":"Bajaj","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.01.007_bib19","first-page":"37","article-title":"Economic impact of the use of rifaximin 550\u00a0mg twice daily for the treatment of overt hepatic encephalopathy in Italy","volume":"9","author":"Roggeri","year":"2017","journal-title":"Hepat Med"},{"issue":"4","key":"10.1016\/j.cld.2020.01.007_bib20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.25507","article-title":"Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis","volume":"55","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2020.01.007_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10620-006-9442-4","article-title":"Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy","volume":"52","author":"Leevy","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2020.01.007_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mayocp.2013.11.009","article-title":"Management of hepatic encephalopathy in the hospital","volume":"89","author":"Leise","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.cld.2020.01.007_bib23","first-page":"945A","article-title":"Assessing treatment patterns in patients with overt hepatic encephalopathy","volume":"56","author":"Neff Guy","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2020.01.007_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11894-013-0362-0","article-title":"Useful tests for hepatic encephalopathy in clinical practice","volume":"16","author":"Nabi","year":"2014","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.cld.2020.01.007_bib25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.26309","article-title":"The stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy","volume":"58","author":"Bajaj","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2020.01.007_bib26","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.cgh.2014.05.011","article-title":"Validation of EncephalApp, smartphone-based stroop test, for the diagnosis of covert hepatic encephalopathy","volume":"13","author":"Bajaj","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2020.01.007_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.29146","article-title":"The animal naming test: an easy tool for the assessment of hepatic encephalopathy","volume":"66","author":"Campagna","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.01.007_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejim.2018.08.008","article-title":"Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy","volume":"60","author":"Beul","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2020.01.007_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ajg.2018.6","article-title":"Diagnosis of minimal hepatic encephalopathy: a systematic review of point-of-care diagnostic tests","volume":"113","author":"Tapper","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2020.01.007_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1331\/JAPhA.2012.11088","article-title":"The \u201ccost\u201d of medication nonadherence: consequences we cannot afford to accept","volume":"52","author":"Chisholm-Burns","year":"2012","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"3","key":"10.1016\/j.cld.2020.01.007_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2015.7667","article-title":"Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis","volume":"176","author":"Thakkar","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.cld.2020.01.007_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/MPG.0000000000001399","article-title":"Text messaging effect on adherence in children with inflammatory bowel disease","volume":"64","author":"Miloh","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.cld.2020.01.007_bib33","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.1542\/peds.2009-0415","article-title":"Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging","volume":"124","author":"Miloh","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.cld.2020.01.007_bib34","first-page":"1","article-title":"Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection","author":"Horvath","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cld.2020.01.007_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2196\/11919","article-title":"Mobile phone apps targeting medication adherence: quality assessment and content analysis of user reviews","volume":"7","author":"Park","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"issue":"5","key":"10.1016\/j.cld.2020.01.007_bib36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/COH.0000000000000401","article-title":"Recent mobile health interventions to support medication adherence among HIV-positive MSM","volume":"12","author":"Muessig","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"10.1016\/j.cld.2020.01.007_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2196\/mhealth.7798","article-title":"Text messaging and mobile phone apps as interventions to improve adherence in adolescents with chronic health conditions: a systematic review","volume":"5","author":"Badawy","year":"2017","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.cld.2020.01.007_bib38","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/STROKEAHA.109.192360","article-title":"A\u00a0review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association\/American Stroke Association","volume":"40","author":"Schwamm","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.cld.2020.01.007_bib39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijmedinf.2015.05.009","article-title":"Systematic review of telemedicine applications in emergency rooms","volume":"84","author":"Ward","year":"2015","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.cld.2020.01.007_bib40","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MIB.0000000000000241","article-title":"Telemedicine in inflammatory bowel disease: opportunities and approaches","volume":"21","author":"Aguas Peris","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cld.2020.01.007_bib41","first-page":"93","article-title":"Management of endocrine disease. Effects of telecare intervention on glycemic control in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials European","volume":"172","author":"Huang","year":"2015","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.cld.2020.01.007_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10067-015-2897-y","article-title":"e-Rheumatology: are we ready?","volume":"34","author":"El Miedanye","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cld.2020.01.007_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1109\/MPULS.2018.2885832","article-title":"The opportunity and obstacles for smartwatches and wearable sensors","volume":"10","author":"Foster","year":"2019","journal-title":"IEEE Pulse"},{"key":"10.1016\/j.cld.2020.01.007_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1550147718779562","article-title":"A\u00a0real-time wireless wearable electroencephalography system based on Support Vector Machine for encephalopathy daily monitoring","volume":"14","author":"Zhang","year":"2018","journal-title":"Int J Distrib Sens Netw"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:57:12Z","timestamp":1761069432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326120300076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1089326120300076"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2020.01.007","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Management","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2020.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}